Physician profile
Christy Walker
NPI 1013951524
$3,301.44
in general payments reported to CMS, 2019-2025
27 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $1,119 · 2021: $571 · 2022: $551 · 2023: $470 · 2024: $191 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.94 |
| Education | $184.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $816.85 | 2020-2021 | |
| Abbvie INC. | $773.20 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $251.94 | 2023-2025 | Veozah |
| Pfizer INC. | $152.27 | 2021-2024 | |
| Eisai INC. | $131.13 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $128.37 | 2022-2025 | |
| Myovant Sciences INC. | $127.27 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $118.93 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $100.00 | 2020 | |
| Hologic Sales and Service, LLC | $92.36 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Organon LLC | $88.88 | 2021-2022 | |
| Avion Pharmaceuticals | $80.04 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $75.86 | 2022-2023 | Quviviq |
| Exeltis, USA INC. | $51.94 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $49.97 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36.01 | 2022 | |
| Dysis Medical, INC. | $32.11 | 2021-2022 | |
| Mimedx Group, INC. | $31.29 | 2025 | |
| Evofem Biosciences, INC. | $22.72 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $20.27 | 2023 | Vivjoa |
| Millicent US INC | $20.01 | 2024 | Intrarosa |
| Merz North America, INC. | $19.23 | 2021 | |
| Baudax Bio INC. | $18.97 | 2020 | |
| Minerva Surgical, INC | $16.75 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $15.59 | 2022 | |
| Scynexis, INC. | $15.36 | 2021 | |
| Therapeuticsmd, INC. | $14.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.